On April 11, 2024, John Chevedden announced that he has filed an exempt solicitation statement with Securities and Exchange Commission, requesting the shareholders of Quest Diagnostics Incorporated to vote for a proposal regarding issue near and long-term science-based greenhouse gas reduction targets aligned with the Paris Agreement?s ambition of limiting global temperature rise to 1.5 °C and summarize plans to achieve them, at the annual meeting of shareholders scheduled to be held on May 16, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.8 USD | +4.89% | +8.16% | +2.05% |
03:55pm | US FDA publishes final rule for laboratory developed tests | RE |
Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.05% | 14.92B | |
-14.82% | 84.68B | |
+14.40% | 81.12B | |
+10.49% | 29.59B | |
-9.58% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.61% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission